Literature DB >> 15686901

Synthesis of argentatin A derivatives as growth inhibitors of human cancer cell lines in vitro.

Hortensia Parra-Delgado1, Teresa Ramírez-Apan, Mariano Martínez-Vázquez.   

Abstract

The syntheses of nine argentatin A analogs are described. These compounds were assessed for their ability to inhibit growth in vitro in four human cancer cell lines. Our results showed that the presence of either a double bond at C-1/C-2, or a bromine atom or formyl moiety at C-2 as well as the presence of an isoxazol ring in argentatin A enhanced its potency in all cell lines tested. In addition, an X-ray study of (16S,17R,20S,24R)-3-oxime-20,24-epoxy-16,25-dihydroxy-cycloartan-3-one led to the determination of the correct stereochemistry of argentatin A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686901     DOI: 10.1016/j.bmcl.2004.12.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  A Higher Frequency Administration of the Nontoxic Cycloartane-Type Triterpene Argentatin A Improved Its Anti-Tumor Activity.

Authors:  Zaira Tavarez-Santamaría; Nadia J Jacobo-Herrera; Leticia Rocha-Zavaleta; Alejandro Zentella-Dehesa; Beatriz Del Carmen Couder-García; Mariano Martínez-Vázquez
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.